Deerfield Management

As we celebrate Women's History Month, we take a moment to honor the incredible contributions of women everywhere, including those who make Deerfield shine. We're proud of our firm’s extraordinary women whose dedication, resilience, and leadership inspire us daily. We're grateful for the perspectives and talent that women bring to the table, making the healthcare and life science community stronger and driving our mission forward. #WomensHistoryMonth #AdvancingHealthcare

Next week, Deerfield's Cameron Wheeler and Scott Donohue are set to take the stage at Cure.'s The Power of X Summit: Solutions for an Untapped Market!?? ? Cameron Wheeler will share his insights on Building an Investment Case: Translational and Commercialization Experience, while Scott Donohue will take us on a policy dive into Healthcare Coverage.? ? The Power of X Summit brings together a distinguished lineup of innovators, CEOs, investors, and academics devising solutions to problems in brain health, cardiovascular disease, autoimmune conditions and oncology.? ? Don't miss the chance to discuss progress in women's health as ideas move from conversation to action to cure! ? Learn more and register today:?https://lnkd.in/eJn7YMWz ? *Cure. is an affiliate of Deerfield Management.

African Mission Healthcare's Scott Marcello & Dene Marcello joined the Deerfield team in our offices this week for a #DeerfieldFoundation Lunch and Learn. With a 2025 grant from the Deerfield Foundation, African Mission Healthcare is funding C-sections and safe vaginal deliveries at Rwibaale Hospital in Southwest Uganda for mothers who cannot otherwise afford safe and compassionate care. Through the Surgical Access For Everyone (SAFE) initiative, the Deerfield Foundation will fund 732 deliveries, benefiting ~1,464 mothers and children. Our support also enables mentorships and training programs for doctors and nurses, further increasing capacity in Uganda’s healthcare system. We are proud to support African Mission Healthcare in their mission to treat patients today, train doctors for tomorrow, and transform hospitals for the future. Learn more about their impactful work: https://lnkd.in/gwVKpGWE

On International Women’s Day, we’re honoring all the great women leaders in our industry who bring diverse perspectives to healthcare boardrooms. Break into the Boardroom (BiB) connects leading healthcare organizations with high-performing female executives for greater impact and better outcomes for all.?Thank you to our sponsors who help us drive our mission forward as we continue to redraw healthcare boardrooms. Deerfield Management | Oxeon | Welsh, Carson, Anderson & Stowe

What happens when you gather industry leaders to explore the challenges and opportunities shaping the future of medicine? ? Cure. decided to find out. During the Yale School of Management's 22nd Annual Private Equity & Venture Capital Symposium, they hosted a Healthcare & Technologies panel where seasoned speakers weighed in on five trends poised to alter existing paradigms. ? Deerfield Management Partner William Slattery likened the industry's recent ups and downs to Dickens's "A Tale of Two Cities." Read more below. (Cure is an affiliate of Deerfield.)

Do you run an NYC-based minority- or woman-led life science startup on the hunt for funding? Don’t miss out on applying for Cure.'s 2025 XSeed Awards! This annual program, founded and funded by Deerfield Management, provides up to $250,000 each to two teams of minority- or women-led life science and healthcare startups based in New York City working on novel drug development projects. To learn more about the XSeed Award’s applicant eligibility criteria and to submit applications, visit https://lnkd.in/ercUPAC3. *Cure is an affiliate of Deerfield.

On this Rare Disease Day, Apertura wants to acknowledge those patients, caregivers, researchers, and organizations that put in tireless hours and efforts to move therapies forward to make a difference. At Apertura we are proud of supporting the work from the teams headed by Ben Deverman and Sonia Vallabh working on a cure for prion disease, https://lnkd.in/eVsnw-jF We hope you will join us in working together to move innovative therapy options for patients forward.

Jack's Tomorrow sat down with Deerfield’s Andrew Steinsapir, a member of the organization’s Scientific Advisory Board, to explore his passion for rare diseases and what makes him hopeful for future treatments. Read the full interview here: https://lnkd.in/giAwaajv Jack’s Tomorrow aims to fund research to develop a treatment – and ultimately a cure – for PURA syndrome, an extremely rare genetic disorder affecting brain development. In commemorating Rare Disease Day, we recognize the dedication of researchers, organizations, and individuals working tirelessly to improve the lives of those affected by rare diseases. #RareDiseaseDay2025

Deerfield’s James Flynn, Karen Heidelberger, Shannon Plumstead, and Dr. Mussaad M. Al-Razouki were delighted to participate in the 2025 #WebSummitQatar! During the summit, we announced a collaboration with the Qatar Investment Authority (QIA) as part of its Fund of Funds VC program, as well as the opening of a regional office in Doha. Through Cure., we’ll also be directing a healthcare startup accelerator program for global and local entrepreneurs. We look forward to collaborating with QIA as our partnership continues to evolve. Learn more: https://lnkd.in/eTB3T-uJ

Did you know only 4% of healthcare R&D funding goes to women's health? Join Deerfield Management partner Cameron Wheeler at The Power of X Summit: Solutions for an Untapped Market, where investors, entrepreneurs, researchers, and policymakers will discuss actionable solutions in brain health, cardiovascular disease, autoimmune conditions and oncology.?